LUNG THERAPEUTICS
Lung Therapeutics is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis. Current efforts are focused on a severe complication of pneumonia, called loculated pleural effusion, a debilitating condition where fluid has built up in the chest cavity surrounding the lungs and fibrinous scar tissue in the pleural cavity blocks fluid drainage. Their first product, LTI-01 (single chain urokinase plasminogen activator, or scuPA), i... s being studied for safe clearance of fibrinous scar tissue in patients with loculated pleural effusion. By clearing the fibrinous buildup pharmaceutically, the clinical pathway for these patients is significantly improved, enabling simple draining of pleural fluid without surgery. Their longer-term efforts will target improvement of clinical pathways for Acute Lung Injury, Idiopathic Pulmonary Fibrosis and other disease conditions.
LUNG THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.lungtx.com
Total Employee:
11+
Status:
Active
Contact:
737-802-1989
Email Addresses:
[email protected]
Total Funding:
53.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Euro
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
O'Dell Family Chiropractic
O'Dell Family Chiropractic provide chiropractic treatments tor a range of health conditions.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bios Partners
Bios Partners investment in Series C - Lung Therapeutics
Bios Partners
Bios Partners investment in Series B - Lung Therapeutics
UT Horizon Fund
UT Horizon Fund investment in Series B - Lung Therapeutics
UT Horizon Fund
UT Horizon Fund investment in Series A - Lung Therapeutics
Texas Venture Labs
Texas Venture Labs investment in Non Equity Assistance - Lung Therapeutics
UT Horizon Fund
UT Horizon Fund investment in Convertible Note - Lung Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-13 | Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development |
Official Site Inspections
http://www.lungtx.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
